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Abstract: Six new flavonols (6a–f) were synthesized with Claisen–Schmidt and Suzuki reactions and 
they were fully characterized by spectroscopic methods. In order to evaluate their antioxidant 
activities, their oxygen radical absorption capacity and ferric reducing antioxidant power were 
measured, along with their free radical scavenging activity against 2,2’-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) and 2,2-diphenyl-1-picrylhydrazylradicals. In addition, 
their cytotoxicity on H9c2 cardiomyoblast cells was also assessed by a 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide assay. Compounds bearing the phenyl-N,N-dimethylamino 
group (6a, 6c, and 6e) exhibited promising antioxidant potency and did not have any cytotoxic 
effect. After a consideration of these data, the oxidative transformation of the 6c compound was 
investigated in vitro with a chemical Fenton reaction and the identification of the formed oxidation 
products was performed by mass spectrometry. Two potential metabolites were detected. Based on 
these results, compound 6c can be a model compound for future developments. Overall, this work 
has proved the involvement of the phenyl-N,N-dimethylamino group in the antioxidant activity of 
flavonols. 
Keywords: antioxidant; flavonoid; flavonol; cytotoxicity; oxidative metabolism 
 
1. Introduction 
During oxidative/nitrosative stress, there is a lack of balance between the endogenous 
antioxidant system and the prooxidants, which could result in the excess formation of the latter. 
Reactive oxygen (ROS) and nitrogen species (RNS) can irreversibly damage lipids, proteins, nucleic 
acids, and other biomacromolecules contributing to the development and progression of several 
diseases, for instance, attention deficit hyperactivity disorder [1], cancer [2], Parkinson’s disease [3], 
Alzheimer’s disease [4], atherosclerosis [5], heart failure [6], and myocardial infarction [7]. In order 
to inhibit lipid peroxidation and protect the cell membranes, proteins, and nucleic acids from the 
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ROS- and RNS-caused damages, the balance must be restored. This can be achieved by providing 
exogenous antioxidants to act as an active contributors of the endogenous antioxidant defense 
system. The most frequently used exogenous antioxidants are ascorbic acid, vitamin E, carotenoids, 
and different polyphenolic compounds, including flavonoids. These exogenous antioxidants are 
mostly produced by plants, and possess promising biological effects [4,8–10]. The flavonoids have 
been studied thoroughly in the past decades; they possess a broad range of beneficial biological 
effects, such as anti-inflammatory, antiviral, antibacterial, and antiallergic activities [11,12]. In further 
studies, flavonoids were proved to be powerful antioxidants [13,14]. Based upon the structural 
complexity, flavonoids can be divided into six groups: anthocyanins, flavan-3-ols, flavanones, 
flavones, isoflavones, and flavonols, which are a 3-hydroxyflavone backboned subclass of flavonoids 
with a wide range of biological activity [15–17]. Furthermore, the authors of the present study have 
previously investigated the antioxidant effects of different flavonoid-type chromone derivatives [18] 
and found that the 4’-N,N-dimethylamino-flavon was the most active tested compound. Hence, the 
amino group promotes free-radical scavenger activity [19]; i.e., the introduction of differentially N-
substituted amino groups into the molecule could modify the antioxidant activity of the different 
flavonoids [20–22]. On the other hand, O-methylation of flavonoids could result in higher metabolic 
stability, increased bioavailability, and better tissue distribution [23–25]; however, the methylation of 
hydroxyl groups could decrease the antioxidant activity [26]. Based on these results, the aim of the 
present work was to evaluate the antioxidant potential and cytotoxic activity of six, newly 
synthetized O-methylated flavonol derivatives (Table 1) and investigate the effect of phenyl-N,N-
dimethylamino and methoxy groups on the antioxidant potency. 
Table 1. The structures of the investigated flavonol derivatives. 
 
ID R R’ Position of R‘-Ph 
6a H 3-N(CH3)2 6 
6b H 4-CH2(O)CH3 6 
6c H 3-N(CH3)2 7 
6d H 4-CH2(O)CH3 7 
6e OMe 3-N(CH3)2 7 
6f OMe 4-CH2(O)CH3 7 
The tested compounds were synthetized by Claisen-Schmidt condensation followed by a ring 
closure. The side chains were built in with a Suzuki reaction. The radical scavenging activity was 
determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS) radical scavenging assays. Moreover, the oxygen radical absorption capacity 
(ORAC) and ferric reducing antioxidant power (FRAP) of the compounds were also measured. In 
further experiments, the cytotoxicity of the compounds was studied by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay on H9c2 cardyomyoblastoma cell cultures. In 
addition, we investigated the oxidative transformation of the molecules by the chemical Fenton 
reaction as a biomimetic model system of biotransformation. 
2. Results and Discussion 
2.1. Chemistry 
Scheme 1 illustrates the preparation of the flavonol backbone (4a–c) used for the synthesis of the 
compounds of interest (6a–f). 
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Scheme 1. Synthesis of 6a-f. Reagents and reaction condition: (i) 1a,b, benzaldehyde 2a,b (1.05 equiv.), 
50% aq. NaOH (4 equiv.), MeOH, room temperature, 24 h; (ii) 3a–c, 8% aq. NaOH (3.1 equiv.), 30% 
H2O2 (14.1 equiv.), EtOH, room temperature, 2 h; (iii) 4a–c, 5a,b (2 equiv.), KF (3 equiv.), Pd(OAc)2 (5 
mol%), XPhos (10 mol%), toluene/t-BuOH (6:1), argon atmosphere, 100 °C, 4 h. 
As a first step, the Claisen-Schmidt condensation of the commercially available 
bromoacetophenones (1a,b) and benzaldehydes (2a,b) in MeOH provided the corresponding 3a–c 
chalcones (88–97%) using 4 equiv. NaOH as a base. The cyclization of these chalcones (3a–c) into the 
4a–c key intermediates (57–76%) was performed using 14.1 equiv. 30% H2O2 in EtOH. Then, the 
Suzuki coupling of bromoflavonol derivatives (4a–c) with the appropriate boronic acid (5a,b) 
resulted in the desired 6a–f flavonols (63–74%) using potassium-fluoride, Pd(OAc)2 as a palladium 
source, and XPhos as a ligand in toluene/t-BuOH (6:1) under argon atmosphere. 
2.2. Antioxidant Activity 
To determine the antioxidant properties of the target compounds, four assays were performed. 
During the ABTS assay, the ABTS radical cation scavenging ability was evaluated. The half-maximal 
scavenging rate (IC50) was calculated for each compound from the inhibition percentage at 120 min 
in the concentration range of 10–200 μM (Figure 1). 
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Figure 1. The IC50 ABTS●+ scavenging rate of the tested flavonol derivatives and quercetin standard. 
The inhibition percentage was determined at 120 min in the concentration range of 10–200 μM. 
The results show that compound 6c demonstrated the highest scavenging potency by having the 
lowest IC50 value, followed by 6e and 6a, in the concentration range of 10–200 μM. By having the 
phenyl-N,N-dimethylamino group, these compounds (6a, 6c, and 6e) are better electron donors than 
compounds with methoxymethyl groups (6b, 6d, and 6f) because of the electronegativity difference. 
During the single electron-transfer process, the ABTS radical cation abstracts an electron and the 
flavonol may act as a donor and, thus, regenerates the original form and causes a detectable change 
in the absorbance at 737 nm. The greater the change in the absorbance, the higher the scavenging 
ability of the investigated compound. The principle of the DPPH assay is similar to that of the ABTS 
assay; i.e., DPPH is a stable radical and its solution is deep violet, since decolorization due to the 
reduction of the radical by the antioxidant can be detected at 515 nm by a spectrophotometer. Figure 
2 depicts the calculated IC50 values for each compound from the inhibition percentage at 90 min in 
the concentration range of 10–200 μM. 
 
Figure 2. The IC50 DPPH scavenging rate of the tested flavonol derivatives and quercetin standard. 
The inhibition percentage was determined at 90 min in the concentration range of 10–200 μM. 
It can be seen that compound 6c was the most potent scavenger against the DPPH radical with 
the lowest IC50 value, followed by 6a, 6d, and 6b at 200 μM concentrations These derivatives (6a, 6b, 
6c, and 6d) have two methoxy groups on the B ring. In a previous report, Kim B. T. et al. reported the 
effect of the substitution pattern of two hydroxyl groups on the B ring in the case of chalcones; the 
ortho- and para- substitution showed much stronger antioxidant potency than meta-substitution, due 
to the efficiency of the ortho- and para-dihydroxylated benzene ring system to delocalize electrons 
[27]. The steric hindrance is higher in the case of the three methoxy groups on the B ring, which 
perturbs planarity, causing the lower antioxidant potency of these derivatives (6f and 6e) as the 
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hydrogen abstraction is easier in planar geometrical configuration [28]. Moreover, in both cases, 6c 
was the most potent compound, which bears the phenyl-N,N-dimethylamino group. These 
observations are in good correlation with Culhaoglu et al., who investigated the antioxidant activity 
of dialkylamino substituted 3-OH-flavon derivatives; the authors found that 4’-N,N-dimethylamino-
3-OH-flavon showed significant scavenging of ABTS and DPPH radicals, and the potency was 
comparable to that of quercetin [20]. Furthermore, earlier, we observed that 4’-N,N-dimethylamino-
flavon was also a good radical scavenger [18]. Thus, the presence of the phenyl-N,N-dimethylamino-
group could have a crucial role in the radical scavenger activity of the molecules. Figure 3 shows the 
results of the FRAP assay of the investigated compounds expressed in μM ferrous equivalents. 
 
Figure 3. FRAP values of the investigated compounds. The fresh FRAP working solution consisted of 
acetate buffer, 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ), and FeCl3, and was incubated at 37 °C for 15 min 
before each experiment. After the activated FRAP reagent was added to the solution of the tested 
compounds and the quercetin standard, the plate was incubated for 30 min. The absorbance was 
measured at 593 nm. The FRAP values are expressed as μM Ferrous equivalents calculated based on 
iron(II) sulfate heptahydrate calibration standard solutions. The experiments were run in duplicate 
and repeated three times. 
The results show that compounds 6c, 6a, and 6e had the highest FRAP values among the 
derivatives at all the tested concentrations, while compounds 6d, 6f, and 6b exhibited significantly 
lower ferrous equivalents. It has to be mentioned that the FRAP value of each compound (6a–f) is 
significantly decreased compared to the standard quercetin. However, this result is not surprising, 
since it had been shown that methoxylated flavonoids are weaker antioxidants than the 
unmethylated ones [26,29]. In their study, Deng et al. found that quercetin had a 650-times higher 
FRAP value then the methylated form. In our experiments, we did not observe such a big difference, 
which could have originated from the presence of the free OH group at position 3 and the phenyl-
N,N-dimethylamino group at ring A. Furthermore, since 6c, 6e, and 6a showed a significantly higher 
FRAP value than 6b, 6d, and 6f suggest that the presence of the phenyl-N,N-dimethylamino group is 
crucial, because the latter three compounds do not bear this group, but they also have the free OH 
group at position 3. Figure 4 depicts the results of the ORAC assay. 
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Figure 4. ORAC values of the compounds of interest expressed in the net area under the curve (AUC). 
To the mixture of tested compounds and fluorescein, the 2,2’-azobis(2-amidinopropane) 
dihydrochloride (AAPH) solution was added rapidly. The fluorescence was monitored at 485 nm 
excitation and 520 nm emission wavelength for 2 h in every 2 min. The assay was performed in 
duplicate and repeated three times. The netAUC was calculated by subtracting the blankAUC from 
sampleAUC. 
Similarly to the findings of Deng et al., the ORAC values did not change as much as the FRAP 
values [29]. The results show that compounds 6e, 6a, and 6b had the highest ORAC value. 
Additionally, in the case of 6e and 6a, the results were comparable to quercetin at a 10 μM 
concentration. Surprisingly, compound 6c exhibited only the fourth highest capacity for the 
absorption of the oxygen radical at each concentration. 
2.3. Cytotoxic Effect 
Figure 5 presents the results of the MTT assay; the cells were treated with 20 μM flavonol 
solutions for 12 h. Compounds with the phenyl-N,N-dimethylamino functional group (6a, 6c and 6e) 
did not exhibit cytotoxic activity; their cell viability percentage was comparable to the untreated 
control value and the quercetin standard. 
 
Figure 5. The effect of the tested compounds and the quercetin standard in 20 μM concentrations on 
the viability of H9c2 cells evaluated by the MTT assay. The cardiomyoblastoma cells were treated for 
12 h and following the addition of the MTT solution, the plates were incubated for 4 h. Absorbance 
was measured at 540 and 630 nm. The measurements were carried out in triplicate and repeated two 
times. 
The results are consistent with the findings of Luo W. et al., who found that 4-dimethylamine 
flavonoid derivatives are protective against oxidative stress-induced cell death in PC12 neurons [30]. 
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Moreover, treatment with compounds 6b, 6d, and 6f significantly decreased the viability of cells, 
which was the most dominant in the case of 6d, which reduced the cell viability to 46% compared to 
the control. These results correlate well with the findings of other research groups who studied the 
effect of the number and position of methoxy groups on the flavonoid backbone on antioxidant and 
cytotoxic potency [24,29,31]. The presence of methoxy groups in these flavonols and other flavonoids 
could be the reason of their cytotoxicity depending on their number and/or positions; however, the 
exact structure-activity relationship is not completely understood. 
2.4. Oxidative Transformation 
Based on the beneficial characteristics of 6c demonstrated by the antioxidant and cytotoxicity 
assays, this compound was selected to determine the possible oxidative transformation pathways 
and identify its potential metabolites. The chemical Fenton reaction was used as a model of phase I 
biotransformation, since it is suitable for modeling phase I metabolic processes, such as N-
dealkylation, O-dealkylation, S-oxidation, benzylic hydroxylation, and aromatic hydroxylation, as it 
has been shown previously [32,33]. Scheme 2 shows the oxidation routes and the potential 
metabolites of compound 6c generated with the chemical Fenton system and detected with 
electrospray ionization mass spectrometry (ESI-MS, spectra not shown); an aromatic hydroxylation 
on the B ring resulted in the product 6c+OH (m/z 434.2) and O-demethylation gave the most abundant 
6cO-CH3 product (m/z 404.1) based on the peak intensity. 
 
Scheme 2. The oxidative transformation routes of compound 6c based on the information obtained 
with the chemical Fenton system. 
These results were also confirmed by LC-MS analysis. The place of the aromatic hydroxylation 
and O-dealkylation was deduced from the characteristic retro Diels-Alder rearrangement 
fragmentation pattern of the 3-hydroxyflavone backbone; however, due to the limitations of the 
detection method used, the exact positions are yet to be determined. The combination of 
electrochemical oxidation and the porphyrin system could yield additional oxidation products, such 
as secondary amine 6cN-CH3 after N-dealkylation, which would have the same m/z as 6cO-CH3. The 
6cN-CH3 could undergo another N-dealkylation, which results in the 6cN-2CH3 primary amine. 
3. Materials and Methods 
3.1. Chemistry 
3.1.1. General Information 
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Thin-layer chromatography with aluminium backed TLC plates of silica gel 60 F254 (0.2 mm, 
Merck, Darmstadt, Germany) under UV light was used to monitor the reactions. Column 
chromatography was performed on silica gel (60, 70−230 mesh, Merck, Darmstadt, Germany). 
Melting points were determined by Büchi B-540 apparatus (Büchi Labortechnik AG, Flawil, 
Switzerland). The purity of the compounds was evaluated using an LTQ XL linear ion trap mass 
spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) with positive ESI. 1H-NMR and 13C-
NMR spectra were acquired on a Bruker AM 360 (360.13 MHz for 1H, 90.03 MHz for 13C) spectrometer 
(Bruker, Billerica, MA, USA). Chemical shifts (δ) are given from internal CHCl3 (δ = 7.26 ppm) or TMS 
(δ = 0.00 ppm) signals for 1H-NMR and CHCl3 (δ = 77.00 ppm) or DMSO (δ = 39.52 ppm) for 13C-NMR 
and reported in parts per million (ppm, d). Coupling constants (J) were measured and reported in 
hertz (Hz). Spectra can be found in supplementary materials. Elemental analyses (C, H, N) were 
performed using the Elementar Vario MicroCube instrument (Elementar Analysensysteme GmbH, 
Langenselbold, Germany). Infrared spectra were obtained in KBr discs using a JASCO FT-IR 4100A 
Fourier-transform infrared spectrometer (Jasco Inc, Easton, MD, USA). 
3.1.2. General Procedure for the Synthesis of 3a–c 
To the stirred solution of the acetophenone (1a,b, 1.29 g, 6 mmol) in MeOH (10 mL) 50% aq. 
NaOH (1.26 mL, 24 mmol) was added. Benzaldehyde (2a,b, 6.3 mmol) suspension in MeOH (5 mL) 
was added to the solution of the acetophenone and the mixture was stirred for 1 h, and then it was 
allowed to stand at room temperature for one day. HCl solution (10%, w/v) was added to reach pH 
1; the precipitate was filtered off and washed with water (3 × 30 mL) to give 3a–c (88–97%). 
(E)-1-(5-Bromo-2-hydroxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (3a). 1H NMR (300 MHz, 298 
K, CDCl3): δ (ppm) = 3.95–3.98 (m, 6H, OMe), 6.89–6.93 (m, 2H, 5-H, 3’-H), 7.17 (s, 1H, 2-H), 7.27–
7.29 (d, J = 7.35 Hz, 1H, 6-H), 7.37-7.41 (d, J= 15.25 Hz, 1H, α-H), 7.53–7.56 (dd, 1H, 4’-H), 7.87–7.92 
(d, J= 15.34 Hz, 1H, β-H), 8.00–8.00 (d, J= 1.62 Hz, 6’-H), 12.89 (s, 1H, OH). 
(E)-1-(4-Bromo-2-hydroxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (3b). 1H NMR (360 MHz, 298 
K, CDCl3): δ (ppm) = 3.94–3.96 (m, 6H, OMe), 6.89–6.91 (d, J = 8.36 Hz, 1H, 5-H), 7.03–7.06 (dd, 1H, 
6-H), 7.14–7.19 (m, 2H, 2-H, 3’-H), 7.23–7.26 (dd, 1H, 5’-H), 7.38–7.42 (d, J = 15.51 Hz, 1H, α-H), 
7.73–7.76 (d, J = 8.36 Hz, 1H, 6’-H), 7.85-7.89 (d, J = 15.63 Hz, 1H, β-H), 13.09 (s, 1H, OH). 
(E)-1-(4-Bromo-2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (3c). 1H NMR (400 MHz, 
298 K, CDCl3): δ (ppm) = 3.92–3.93 (m, 9H, OMe), 6.87 (s, 2H, 2-H, 6-H), 7.05–7.07 (d, J= 7.70 Hz, 1H, 
5’-H), 7.20 (s, 1H, 3’-H), 7.41–7.45 (d, J= 15.40 Hz, 1H, α-H), 7.74–7.77 (d, J= 7.70 Hz, 1H, 6’-H), 7.82–
7.86 (d, J= 15.40 Hz, 1H, β-H), 12.99 (s, 1H, OH). 
3.1.3. General Procedure for the Synthesis of 4a–c 
To the water-bath cooled suspension of chalcone (3a–c, 2.7 mmol) in EtOH (15 mL), 8% aq. 
NaOH (3.9 mL, 8.41 mmol) was added to result in a solution. To the mixture, 30% H2O2 (3.9 mL, 38.2 
mmol) was added dropwise, and then it was stirred at room temperature for 2 h. The reaction mixture 
was poured into ice-water mixture (250 mL) and 10% HCl solution was added to reach pH 1. The 
precipitate was allowed to sedimentate for one day, then filtered off and washed with cc. NaHCO3 
solution (2 × 50 mL) and water (4 × 50 mL) to give 4a–c (57–76%). 
6-Bromo-2-(3,4-dimethoxyphenyl)-3-hydroxy-4H-chromen-4-one (4a). 1H NMR (360 MHz, 298 K, DMSO-
D6): δ (ppm) = 3.85 (s, 6H, OMe), 7.14–7.16 (d, J = 7.85 Hz, 1H, 5’-H), 7.80–7.82 (m, 3H, 2’-H, 6’-H), 
7.87–7.90 (d, J = 8.16 Hz, 1H, 8-H), 7.93–7.96 (dd, 7-H), 8.16–8.16 (d, J = 1.92 Hz, 1H, 5-H), 9.72 (s, 1H, 
OH). 
7-Bromo-2-(3,4-dimethoxyphenyl)-3-hydroxy-4H-chromen-4-one (4b).1H NMR (400 MHz, 298 K, DMSO-
D6): δ (ppm) = 3.85–3.86 (m, 6H, OMe), 7.14–7.16 (d, J = 8.02 Hz, 1H, 5’-H), 7.61–7.64 (dd, 1H, 6’-H) 
7.81–7.81 (d, J = 1.67 Hz, 1H, 2’-H), 7.90–7.93 (dd, 1H, 6-H), 8.00–8.02 (d, J = 8.55 Hz, 5-H), 8.20–8.20 
(d, J = 1.44 Hz, 1H, 8-H), 9.63 (s, 1H, OH). 
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7-Bromo-3-hydroxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (4c). 1H NMR (400 MHz, 298 K, 
DMSO-D6): δ (ppm) = 3.75 (s, 3H, 4’-MeO), 3.86 (s, 6H, 3’-MeO, 5’-MeO), 7.56 (s, 2H, 2’-H, 6’-H), 7.59–
7.62 (d, J = 8.46 Hz, 1H, 6-H), 7.98–8.00 (d, J = 8.46 Hz, 5-H), 8.21 (s, 1H, 8-H), 9.74 (s, 1H, OH). 
3.1.4. General Procedure for the Synthesis of 6a–f 
Into a pressure tube, under argon, the mixture of 3-hydroxyflavone (4a–c, 0.265 mmol), KF (46.3 
mg, 0.795 mmol), Pd(OAc)2 (3 mg, 0.0133 mmol) and XPhos (12.6 mg, 0.0265 mmol), and boronic acid 
(5a,b, 0.53 mmol) in toluene/t-BuOH (6:1, 3.5 mL) were added. The mixture was stirred and heated 
in a 100 °C oil bath for 4 h. The solvent was removed under reduced pressure, and the residue was 
purified by absorptive filtration using toluene/EtOAc (2:1) as the eluent. The crude product was 
washed with i-Pr2O and filtered to give pure products 6a–f (63–74%). 
2-(3,4-Dimethoxyphenyl)-6-[3-(dimethylamino)phenyl]-3-hydroxy-4H-chromen-4-one (6a). Yellow solid; 
yield 69.1 mg (63%). Mp. 187.7–188.8 °C. Rf: 0.35 (toluene/EtOAc, 2:1). 1H NMR (360 MHz, 298 K, 
CDCl3): δ (ppm) = 3.02 (s, 6H, N(Me)2), 3.95–3.99 (m, 6H, OMe), 6.75–6.77 (d, J = 7.35 Hz, 1H, 6”-H), 
6.97–6.99 (m, 3H, 8-H, 5’-H, 2”-H), 7.13–7.17 (m, 1H, 2’-H), 7.30–7.34 (m, 1H, 5”-H), 7.60 (s, 1H, OH), 
7.85–7.90 (m, 3H, 7-H, 6’-H, 4”-H), 8.42 (s, 1H, 5-H). 13C NMR (91 MHz, 298 K, CDCl3): δ (ppm) = 40.8 
(C-N(Me)2), 56.0, 56.1 (C-3’-MeO, 4’-MeO), 110.8 (C-2’), 111.1 (C-5’), 111.3 (C-2”), 112.2 (C-4”), 115.7 
(C-6”), 118.5 (C-8), 120.8 (C-1’), 121.6 (C-6’), 123.1 (C-5), 123.8 (C-4a), 129.7 (C-5”), 132.8 (C-7), 137.9 
(C-3), 138.7 (C-6), 140.3 (C-1”), 145.2 (C-4’), 148.9 (C-3’), 150.8(C-3”), 151.1 (C-2), 154.6 (C-8a),173.3 (C-
4). LC-MS: m/z = 418.42 [M + H]+. IR (KBr, cm−1): ν = 3292, 2934, 2839, 1605, 1561, 1516, 1489, 1463.71, 
1430, 1381, 1338, 1271, 1247, 1216, 1195, 1149, 1118, 1042, 1024, 991, 964, 933, 901, 869, 814, 770, 724, 
694, 665, 634. Anal. Calcd for C25H23NO5: C, 71.93; H, 5.55; Found: C 71.79; H 5.52. 
2-(3,4-Dimethoxyphenyl)-3-hydroxy-6-[4-(methoxymethyl)phenyl]-4H-chromen-4-one (6b). Yellow solid; 
yield 80.3 mg (72%). Mp. 192.8–194.3 °C. Rf: 0.30 (toluene/EtOAc, 2:1). 1H NMR (360 MHz, 298 K, 
CDCl3): δ (ppm) = 3.43 (s, 3H, Bn-MeO), 3.96–4.00 (m, 6H, 3’-MeO, 4’-MeO), 4.52 (s, 2H, Bn-H2), 7.00–
7.02 (d, J = 7.37 Hz, 1H, 5’-H), 7.08 (s, 1H, 2’-H), 7.43–7.45 (d, J = 7.55 Hz, 2H, 2”-H, 6”-H), 7.62–7.69 
(m, 3H, OH, 3”-H, 5”-H), 7.86–7.93 (m, 3H, 7-H, 8-H, 6”-H), 8.43 (s, 1H. 5-H). 13C NMR (91 MHz, 298 
K, CDCl3): δ (ppm) = 56.1, 56.1 (C-3’-MeO, 4’-MeO), 58.4 (C-Bn-MeO), 74.4 (C-Bn-CH2), 110.9 (C-2’), 
111.1 (C-5’), 118.8 (C-8), 120.9 (C-1’), 121.6 (C-6’), 123.1 (C-5), 123.8 (C-4a), 127.3 (C-2”, C-6”), 128.4 (C-
3”, C-5”), 132.4 (C-7), 137.4 (C-4”),138.0 (C-3), 138.1 (C-6), 138.7 (C-1”), 145.2 (C-4’), 149.0 (C-3’), 150.9 
(C-2), 154.7 (C-8a), 173.2 (C-4). LC-MS: m/z = 419.33 [M + H]+. IR (KBr, cm−1): ν = 3265, 3030, 2993, 2939, 
2833, 2737, 2603, 2039, 1922, 1843, 1801, 1714, 1601, 1561, 1516, 1483, 1459, 1411, 1388, 1336, 1298, 1269, 
1218, 1197, 1174, 1148, 1112, 1025, 967, 944, 932, 904, 875, 857, 815, 806, 784, 770, 727, 699, 661, 629. 
Anal. Calcd for C25H22O6: C, 71.76; H, 5.30; Found: C 71.95; H 5.29. 
2-(3,4-Dimethoxyphenyl)-7-[3-(dimethylamino)phenyl]-3-hydroxy-4H-chromen-4-one (6c). Pale-brown 
solid; yield 79.0 mg (71%). Mp. 191.6moved outside the brackets192.7 °C. Rf: 0.39 (toluene/EtOAc, 
2:1). 1H NMR (400 MHz, 298 K, CDCl3): δ (ppm) = 3.04 (s, 6H, N(Me)2), 3.96–3.99 (m, 6H, OMe), 6.79–
6.81 (d, J = 7.84 Hz, 1H, 6”-H), 6.97–7.02 (m, 3H, 8-H, 5’-H, 2”-H), 7.10 (s, 1H, 2’-H), 7.33–7.37 (m, 1H, 
5”-H), 7.63–7.65 (d, J= 7.84 Hz, 1H, 6-H), 7.75 (s, 1H, OH), 7.87–7.91 (m, 2H, 6’-H, 4”-H), 8.24–8.26 (d, 
J = 7.83 Hz, 1H, 5-H). 13C NMR (101 MHz, 298 K, CDCl3): δ (ppm) = 40.8 (C-N(Me)2), 56.1, 56.2 (C-3’-
MeO, 4’-MeO), 110.9 (C-2’), 111.0 (C-5’), 111.4 (C-2”), 112.9 (C-4”), 115.9 (C-6”), 116.2 (C-8), 119.4 (C-
1’), 121.5 (C-6’), 123.9 (C-4a), 124.1 (C-6), 125.7 (C-5), 129.8 (C-5”), 138.0 (C-3), 140.3 (C-1”), 145.3 (C-
4’), 147.8 (C-7), 149.0 (C-3’), 150.8 (C-3”), 151.1 (C-2), 155.6 (C-8a), 173.0 (C-4). LC-MS: m/z = 418.42 [M 
+ H]+. IR (KBr, cm−1): ν = 3228, 3028, 2992, 2919, 2847, 2800, 2592, 2034, 1940, 1885, 1713, 1617, 1576, 
1555, 1514, 1489, 1453, 1428, 1397, 1346, 1265, 1236, 1213, 1171, 1147, 1111, 1039, 1024, 994, 969, 921, 
883, 861, 847, 835, 821, 771, 717, 699, 648, 639. Anal. Calcd for C25H23NO5: C, 71.93; H, 5.55; Found: C 
71.97; H 5.52. 
2-(3,4-Dimethoxyphenyl)-3-hydroxy-7-[4-(methoxymethyl)phenyl]-4H-chromen-4-one (6d). Yellow solid; 
yield 79.3 mg (72%). Mp. 212.1–214.2 °C. Rf: 0.31 (toluene/EtOAc, 2:1). 1H NMR (400 MHz, 298 K, 
CDCl3): δ (ppm) = 3.44 (s, 3H, Bn-MeO), 3.96–4.00 (m, 6H, 3’-MeO, 4’-MeO), 4.53 (s, 2H, Bn-H2), 6.99–
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7.01 (d, J = 7.46 Hz, 1H, 5’-H), 7.10 (s, 1H, 2’-H), 7.46–7.48 (m, 2H, 2”-H, 6”-H), 7.62–7.69 (m, 3H, 6-H, 
3”-H, 5”-H), 7.75 (s, 1H, OH), 7.85–7.91 (m, 2H, 8-H, 6’-H), 8.25–8.27 (d, J = 7.46 Hz, 1H, 5-H). 13C NMR 
(101 MHz, 298 K, CDCl3): δ (ppm) = 56.1, 56.1 (C-3’-MeO, 4’-MeO), 58.4 (C-Bn-MeO), 74.3 (C-Bn-CH2), 
110.8 (C-2’), 111.0 (C-5’), 116.0 (C-8), 119.5 (C-1’), 121.6 (C-6’), 123.7 (C-6), 123.8 (C-4a), 125.9 (C-5), 
127.5 (C-2”, C-6”), 128.4 (C-3”, C-5”), 138.0 (C-3), 138.5 (C-4”), 139.1 (C-1”), 145.3 (C-4’), 146.3 (C-7), 
149.0 (C-3’), 150.8 (C-2), 155.6 (C-8a), 172.9 (C-4). LC-MS: m/z = 419.42 [M + H]+. IR (KBr, cm−1): ν = 
3234, 3022, 2977, 2920, 2839, 2597, 2030, 1923, 1848, 1797, 1714, 1611, 1574, 1555, 1515, 1488, 1467, 1450, 
1417, 1397, 1354, 1333, 1271, 1243, 1212, 1173, 1147, 1103, 1039, 1020, 914, 858, 843, 818, 807, 774, 706, 
635. Anal. Calcd for C25H22O6: C, 71.76; H, 5.30; Found: C 71.70; H 5.32. 
7-[3-(Dimethylamino)phenyl]-3-hydroxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (6e). Pale-brown 
solid; yield 88.2 mg (74%). Mp. 179.5–181.8 °C. Rf: 0.47 (toluene/EtOAc, 2:1). 1H NMR (360 MHz, 298 
K, CDCl3): δ (ppm) = 3.04 (s, 6H, N(Me)2), 3.95 (s, 3H, 4’-MeO), 3.97 (s, 6H, 3’-MeO, 5’-MeO), 6.80–
6.82 (d, J = 7.17 Hz, 1H, 6”-H), 6.97–7.03 (m, 2H, 8-H, 2”-H), 7.15–7.17 (d, J = 7.17 Hz, 1H, 4”-H), 7.34–
7.37 (m, 1H, 5”-H), 7.56 (s, 2H, 2’-H, 6’-H), 7.64–7.66 (d, J = 7.96 Hz, 1H, 6-H), 7.76 (s, 1H, OH), 8.25–
8.27 (d, J = 8.22 Hz, 1H, 5-H). 13C NMR (91 MHz, 298 K, CDCl3): δ (ppm) = 40.8 (C-N(Me)2), 56.4 (C-3’-
MeO, 5’-MeO), 61.1 (C-4’), 105.6 (C-2’ C-6’), 111.5 (C-2”), 113.0 (C-4”), 115.9 (C-6”), 116.3 (C-8), 119.3 
(C-1’), 126.4 (C-4a), 124.3 (C-6), 125.7 (C-5), 129.9 (C-5”), 138.4 (C-3), 140.2 (C-1”), 144.8 (C-4’), 148.1 
(C-7), 151.1 (C-2), 151.2 (C-3”), 153.3 (C-3’, C-5’), 155.7 (C-8a), 173.2 (C-4). LC-MS: m/z = 448.33 [M + 
H]+. IR (KBr, cm−1): ν = 3247, 3079, 2999, 2968, 2938, 2838, 1603, 1579, 1556, 1504, 1453, 1427, 1393, 1353, 
1283, 1263, 1242, 1209, 1172, 1127, 1057, 1027, 1011, 994, 928, 841, 831, 821, 773, 734, 714, 697, 652. Anal. 
Calcd for C26H25NO6: C, 69.79; H, 5.63; Found: C 69.86; H 5.59. 
3-Hydroxy-7-[4-(methoxymethyl)phenyl]-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one (6f). Brown solid; 
yield 82.0 mg (69%). Mp. 208.1–209.2 °C. Rf: 0.48 (toluene/EtOAc, 2:1). 1H NMR (400 MHz, 298 K, 
CDCl3): δ (ppm) = 3.45 (s, 3H, Bn-MeO), 3.95 (s, 3H, 4’-MeO), 3.98 (s, 6H, 3’-MeO, 5’-MeO), 4.54 (s, 
2H, Bn-H2), 7.15 (s, 1H, 8-H), 7.48 (s, 2H, 2’-H, 6’-H), 7.56 (s, 2H, 2”-H, 6”-H), 7.63–7.69 (m, 3H, 6-H, 
3”-H, 5”-H), 7.77 (s, 1H, OH), 8.26–8.28 (d, J = 7.47 Hz, 1H, 5-H). 13C NMR (101 MHz, 298 K, CDCl3): 
δ (ppm) = 56.4 (C-3’-MeO, 5’-MeO), 58.4 (C-Bn-MeO), 61.1 (C-4’), 74.3 (C-Bn-CH2), 105.5 (C-2’), 116.1 
(C-8), 119.4 (C-1’), 123.9 (C-6), 126.4 (C-4a), 126.0 (C-5), 127.5 (C-2”, C-6”), 128.4 (C-3”, C-5”), 138.4 (C-
3), 138.5 (C-4”), 139.2 (C-1”), 140.1 (C-2), 144.8 (C-4’), 146.6 (C-7), 153.3 (C-3’, C-5’), 155.7 (C-8a), 173.1 
(C-4). LC-MS: m/z = 449.33 [M + H]+. IR (KBr, cm−1): ν = 3278, 3010, 2983, 2969, 2939, 2899, 2837, 2154, 
2064, 2010, 1928, 1602, 1583, 1574, 1551, 1508, 1491, 1451, 1409, 1394, 1379, 1338, 1296, 1244, 1211, 1194, 
1172, 1130, 1114, 1056, 1026, 1011, 970, 936, 930, 913, 887, 844, 824, 779, 765, 712, 671, 624. Anal. Calcd 
for C26H24O7: C, 69.63; H, 5.39; Found: C 69.57; H 5.43. 
3.2. Antioxidant Activity and Cytotoxicity 
3.2.1. Chemicals 
Water (ultra-pure) was prepared with the SolPure 78 water purification system from POL-LAB 
(Bielsko-Biała, Poland). Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-Na2), L(+)-
ascorbic acid, ethanol (96%), acetic acid, and formic acid were obtained from Scharlab Magyarország 
Kft. (Debrecen, Hungary). DMSO, methanol, hydrogen peroxide solution, 2,2-diphenyl-1-
picrylhydrazyl (DPPH), glacial acetic acid, sodium acetate, HCl, 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ), 
FeCl3, iron(II) sulfate heptahydrate, fluorescein, 2,2′-azobis (2-amidinopropane) dihydrochloride 
(AAPH), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), potassium hydrogen 
phosphate, monopotassium phosphate, and K2S2O8 were obtained from Sigma-Aldrich Kft. 
(Budapest, Hungary). Acetonitrile (ACN) was ordered from Merck (Darmstadt, Germany). 2,2’-
Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS salt) was purchased 
from Fluorochem Ltd. (Hadfield, United Kingdom). 
3.2.2. ABTS Assay 
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To measure the ABTS radical scavenging activity, the work of Sugahara et al. and Re et al. was 
followed closely, applying few alterations [34,35]. A mixture containing 7 mM ABTS and 2.45 mM 
K2S2O8 in water was kept in the dark for 16 h to form ABTS•+. The working solution was prepared by 
adding 150 μL of ABTS•+ solution to 2.9 mL MeOH. Aliquots of 180 μL of this working solution were 
pipetted into wells containing 20 μL of test samples in DMSO with different concentrations (10, 20, 
50, 100, and 200 μM). Absorbance was measured at 737 nm after 10 s mixing using a Multiskan GO 
microplate spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) at 0, 1, 2, 3, 4, 5, 10, 15, 
30, 45, 60, 75, 90, 105, and 120 min. Quercetin was used as the standard. The IC50 values were 
calculated based on the inhibition percentage measured at 120 min. The experiments were carried 
out in duplicate and repeated three times. 
3.2.3. DPPH Assay 
The method used for the DPPH radical scavenging assay was adopted from Clarke et al., with 
modifications [36]. A total of 180 μL freshly made 0.2 mM DPPH solution in methanol was added to 
20 μL of the investigated compounds in various concentrations (10, 20, 50, 100, and 200 μM) in DMSO. 
After a gentle, 10-s mixing period, the plate was kept in the dark for 90 min. and the absorbance was 
read at 515 nm using a Multiskan GO microplate spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA) at 0, 1, 2, 3, 4, 5, 10, 15, 30, 45, 60, 75, and 90 min. Blanks (20 μL DMSO with 180 
μL MeOH) and quercetin standards in the same concentration as the tested compounds were 
measured simultaneously. The IC50 values were calculated based on the inhibition percentage 
measured at 90 min. The measurements were performed in duplicate and repeated three times. 
3.2.4. FRAP Assay 
The ferric reducing antioxidant power of the compounds was tested with a modified method of 
Benzie and Strain [37]. The FRAP reagent consisted of 10 mL acetate buffer (300 mM, pH 3.6), 1 mL 
TPTZ solution (10 mM) in 40 mM HCl, and 1 mL FeCl3 (10 mM). The mixture was incubated at 37 °C 
for 15 min and used on the same day. The reaction mixture was prepared by 20 μL of the investigated 
compound (10, 20, 50, 100, and 200 μM) and 180 μL activated FRAP reagent in a 96-well plate. 
Following a 30 min incubation period, the absorbance was measured at 593 nm by a Multiskan GO 
microplate spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Iron (II) sulfate 
heptahydrate was used as the standard in different concentrations (0.5, 1, 5, 10, 50, 100, and 500 μM). 
The FRAP values are expressed as μM ferrous equivalents. The experiments were run in duplicate 
and repeated three times. 
3.2.5. ORAC Assay 
The oxygen radical absorbance capacity was evaluated using the ORAC assay. The test was 
carried out in a black 96-well plate with a black bottom. The stock solutions of 50 nM fluorescein and 
180 mM AAPH in phosphate buffer (75 mM, pH 7.00) were prepared freshly and used on the same 
day. To each well, 20 μL of compound in ACN (2 and 10 μM) was added to 160 μL fluorescein. In the 
case of blank samples, 20 μL of ACN was added. The plate was incubated for 15 min at 37 °C, and 
then the 20 μL AAPH solution was rapidly added to each well to initiate the reaction. The 
fluorescence was monitored at 485 nm excitation and 520 nm emission wavelength for 2 h every 2 
min by the FLUOstar OPTIMA (BMG Labtech, Ortenberg, Germany) plate reader. The assay was 
performed in duplicate and repeated three times. The area under the curve (AUC) was calculated as 
follows: 
AUC = 0.5 + (A1/A0) + (A2/A0) + (A3/A0) +···+ (An/A0), (1)
where A0 is the fluorescence reading at 0 min and An is the fluorescence reading at n min. The 
reported ORAC values were calculated by subtracting the blank AUC from the sample AUC and 
expressed as AUCnet. 
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AUCnet = AUCsample – AUCblank (2)
3.2.6. MTT Assay 
The MTT assay was used to determine the effect of the investigated compounds on the cell 
viability. H9c2 cells (ATCC, CRL-1446, LGC Standards GmbH, Wesel, Germany) were seeded into 
96-well plates at a density of 6000 cells/well in 200 μL media (DMEM, high glucose, pyruvate from 
Thermo Fischer Scientific with 10% FBS and supplemented with penicillin and streptomycin) and 
cultured overnight. The flavonols were added to the cells in 20 μM concentration. After 12 h, 20 μL 
of MTT solution (5 mg/μL in PBS) was added to each well, and the plates were incubated for 4 h. 
Afterwards, the media was carefully removed and 100 μL DMSO was added to each well to dissolve 
the formazan crystals. Absorbance was measured at 540 and 630 nm using a Synergy HT plate reader 
(BioTek, Winooski, VT, USA). The tests were carried out in triplicate and repeated two times. 
3.3. Oxidative Transformation 
Chemical Fenton Reaction 
The Fenton reaction of the compounds was carried out based on a method reported previously 
by Csepanyi et al. [18]. The reaction mixture consisted of 400 μL 2.5 mM of the investigated 
compound in ACN, 50 μL 20 mM FeCl3, 50 μL 20 mM EDTA-Na2, and 500 μL 10 mM ascorbic acid in 
ACN/H2O (50:50) and 2 μL 30% hydrogen peroxide. The reaction mixture was stirred at room 
temperature at 700 rpm. Samples were drawn at 2, 24, 72, and 144 h and were diluted with ACN/H2O 
(50:50) and analyzed immediately by an API 2000 Triple Quadrupole mass spectrometer (Applied 
Biosystems, Waltham, MA, USA) equipped with a syringe pump with the following parameters: 20 
μL/min flow rate, 10 PSI curtain gas, 20 V declustering potential, 4000 V ion spray voltage, 400 V 
focusing potential, and 200 °C ion source temperature. The positive ion electrospray mass spectra 
were recorded in the range of m/z 100–500 using Analyst 1.5.1. Software (AB SCIEX, Concord, ON, 
Canada). In additional experiments, the reaction mixture was separated and analyzed with an LTQ 
XL linear ion trap mass spectrometer coupled with the Accela LC system (Thermo Fisher Scientific, 
Waltham, MA, USA). The HPLC separation was performed using a Kinetex XB-C18 2.6 μm column, 
0.1% formic acid in water, and ACN with 0.1% formic acid with gradient elution, and the flow rate 
was set to 300 μL/min. The method parameters for mass spectrometry were the followings: 35 a.u. 
sheath gas flow rate, 5000 V spray voltage, 300 °C capillary temperature, 31 V capillary voltage, 150 
V tube lens voltage, and 34 V skimmer voltage. 
4. Conclusions 
In conclusion, six new flavonol derivatives were designed and synthetized, and their biological 
activity was evaluated. The results of four antioxidant assays showed that three compounds (6a, 6c, 
and 6e) were potent antioxidants. Each of these molecules bear with a phenyl-N,N-dimethylamino 
group on ring A. Furthermore, compounds 6a, 6c, and 6e did not show any cytotoxic activity on H9c2 
cells during the MTT assay, when 20 μM solutions were tested. According to the experimental data, 
the position of the phenyl-N,N-dimethylamino group did not significantly affect the antioxidant 
potential. However, because compound 6c showed improved antioxidant activity among compounds 
with a phenyl-N,N-dimethylamino substituent, this molecule was selected for further studies, in 
which the oxidative biotransformation of the molecule was modeled by a biomimetic system; the 
chemical Fenton reaction. As a result of these experiments, two potential metabolites were detected, 
which were the products of O-demethylation and aromatic hydroxylation of compound 6c. These 
results identify compound 6c as a potential subject of additional investigations and a prototype of 
promising flavonol-type antioxidants in further developments. Furthermore, to the authors’ best 
knowledge, this is the first time that the dimethylamino group has been proven to be involved in the 
antioxidant activity in flavonols. 
Molecules 2018, 23, 3161 13 of 15 
 
Supplementary Materials: The supplementary materials are available online at www.mdpi.com/xxx/s1. 
Author Contributions: Conceptualization, I.B.; Data curation, P.S.-F.; Funding acquisition, A.T. and I.B.; 
Investigation, P.S.-F., D.P., A.B., and A.K.-S.; Methodology, A.K.-S.; Project administration, I.B.; Resources, I.B.; 
Supervision, I.B.; Visualization, P.S.-F., D.P., and A.B.; Writing – original draft, P.S.-F.; Writing – review & 
editing, P.S.-F., E.C., A.K.-S., and I.B. 
Funding: This study was supported by the GINOP-2.3.2-15-2016-00043 project and co-financed by the European 
Union and the European Regional Development Fund. The project was subsidized by the European Union and 
co-financed by the European Social Fund. 
Acknowledgments: The work of Peter Szabados-Furjesi and David Pajtas was supported by the EFOP-3.6.1-16-
2016-00022 “Debrecen Venture Catapult Program”. Evelin Csepanyi assisted in fundamental research in the 
frame of TÁMOP-4.2.4. A/2-11-1-2012-0001. National Excellence Program-elaborating and operating an inland 
student and researcher personal support system was realized with personal support. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Joseph, N.; Zhang-James, Y.; Perl, A.; Faraone, S.V. Oxidative Stress and ADHD: A Meta-Analysis. J. Atten. 
Disord. 2015, 19, 915–924, doi:10.1177/1087054713510354. 
2. Halliwell, B. Oxidative stress and cancer: Have we moved forward? Biochem. J. 2007, 401, 1–11, 
doi:10.1042/BJ20061131. 
3. Hwang, O. Role of oxidative stress in Parkinson’s disease. Exp. Neurobiol. 2013, 22, 11–17, 
doi:10.5607/en.2013.22.1.11. 
4. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in 
normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84, 
doi:10.1016/j.biocel.2006.07.001. 
5. Bonomini, F.; Tengattini, S.; Fabiano, A.; Bianchi, R.; Rezzani, R. Atherosclerosis and oxidative stress. Histol. 
Histopathol. 2008, 23, 381–390, doi:10.14670/HH-23.381. 
6. Singh, N.; Dhalla, A.K.; Seneviratne, C.; Singal, P.K. Oxidative stress and heart failure. Mol. Cell Biochem. 
1995, 147, 77–81. 
7. Ramond, A.; Godin-Ribuot, D.; Ribuot, C.; Totoson, P.; Koritchneva, I.; Cachot, S.; Levy, P.; Joyeux-Faure, 
M. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam. Clin. 
Pharmacol. 2013, 27, 252–261, doi:10.1111/j.1472-8206.2011.01015.x. 
8. Andre, C.M.; Larondelle, Y.; Evers, D. Dietary Antioxidants and Oxidative Stress from a Human and Plant 
Perspective: A Review. Curr. Nutr. Food Sci. 2010, 6, 2–12, doi:10.2174/157340110790909563. 
9. Hercberg, S.; Galan, P.; Preziosi, P.; Alfarez, M.-J.; Vazquez, C. The potential role of antioxidant vitamins 
in preventing cardiovascular diseases and cancers. Nutrition 1998, 14, 513–520, doi:10.1016/S0899-
9007(98)00040-9. 
10. Cadenas, E.; Packer, L. Handbook of Antioxidants. Marcel Dekker: New York, NY, USA, 2002. 
11. Cushnie, T.P.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343–356. 
12. Di Carlo, G.; Mascolo, N.; Izzo, A.A.; Capasso, F. Flavonoids: Old and new aspects of a class of natural 
therapeutic drugs. Life Sci. 1999, 65, 337–353. 
13. Luisa Helena, C.; Leila, Z.; Elga Heloisa, A.; Maria Santos Reis Bonorino, F.; Poliane, F.; Rosangela Guollo, 
D.; Moacir Geraldo, P.; Fatima Regina Mena Barreto, S. Flavonoids: Prospective Drug Candidates. Mini-
Rev. Med. Chem. 2008, 8, 1429–1440, doi:/10.2174/138955708786369564. 
14. Shahidi, F.; Wanasundara, P.K. Phenolic antioxidants. Crit. Rev. Food Sci. Nutr. 1992, 32, 67–103, 
doi:10.1080/10408399209527581. 
15. Federico, D.; Abin-Carriquiry Juan, A.; Arredondo, F.; Echeverry, C.; Rivera-Megret, F. Neuroprotective 
Actions of Flavones and Flavonols: Mechanisms and Relationship to Flavonoid Structural Features. Cent. 
Nerv. Syst. Agents Med. Chem. 2013, 13, 30–35, doi:/10.2174/1871524911313010005. 
16. Gomez-Pinilla, F. Brain foods: The effects of nutrients on brain function. Nat. Rev. Neurosci. 2008, 9, 568–
578, doi:10.1038/nrn2421. 
17. Lu, K.-H.; Chen, P.-N.; Hsieh, Y.-H.; Lin, C.-Y.; Cheng, F.-Y.; Chiu, P.-C.; Chu, S.-C.; Hsieh, Y.-S. 3-
Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and 
Molecules 2018, 23, 3161 14 of 15 
 
repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor 
growth in vivo. Food Chem. Toxicol. 2016, 97, 177–186, doi:/10.1016/j.fct.2016.09.006. 
18. Csepanyi, E.; Szabados-Furjesi, P.; Kiss-Szikszai, A.; Frensemeier, L.M.; Karst, U.; Lekli, I.; Haines, D.D.; 
Tosaki, A.; Bak, I. Antioxidant Properties and Oxidative Transformation of Different Chromone 
Derivatives. Molecules 2017, 22, doi:10.3390/molecules22040588. 
19. Bendary, E.; Francis, R.R.; Ali, H.M.G.; Sarwat, M.I.; El Hady, S. Antioxidant and structure–activity 
relationships (SARs) of some phenolic and anilines compounds. Ann. Agric. Sci. 2013, 58, 173–181, 
doi:/10.1016/j.aoas.2013.07.002. 
20. Culhaoglu, B.; Capan, A.; Boga, M.; Ozturk, M.; Ozturk, T.; Topcu, G. Antioxidant and Anticholinesterase 
Activities of Some Dialkylamino Substituted 3-Hydroxyflavone Derivatives. Med. Chem. 2017, 13, 254–259, 
doi:/10.2174/1573406412666161104121642. 
21. Dauzonne, D.; Folléas, B.; Martinez, L.; Chabot, G.G. Synthesis and in vitro cytotoxicity of a series of 3-
aminoflavones. Eur. J. Med. Chem. 1997, 32, 71–82, doi:/10.1016/S0223-5234(97)84363-2. 
22. Liu, G.; Ge, Z.; Zhao, M.; Zhou, Y. Design, Synthesis and cytotoxic activities of novel aliphatic amino-
substituted flavonoids. Molecules 2013, 18, 14070–14084. 
23. Chen, L.; Teng, H.; Xie, Z.; Cao, H.; Cheang, W.S.; Skalicka-Woniak, K.; Georgiev, M.I.; Xiao, J. 
Modifications of dietary flavonoids towards improved bioactivity: An update on structure–activity 
relationship. Crit. Rev. Food Sci. Nutr. 2018, 58, 513–527, doi:10.1080/10408398.2016.1196334. 
24. Walle, T.; Ta, N.; Kawamori, T.; Wen, X.; Tsuji, P.A.; Walle, U.K. Cancer chemopreventive properties of 
orally bioavailable flavonoids--methylated versus unmethylated flavones. Biochem. Pharmacol. 2007, 73, 
1288–1296, doi:10.1016/j.bcp.2006.12.028. 
25. Wen, X.; Walle, T. Methylated flavonoids have greatly improved intestinal absorption and metabolic 
stability. Drug Metab. Dispos. 2006, 34, 1786–1792, doi:10.1124/dmd.106.011122. 
26. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and prooxidant behavior of flavonoids: Structure-activity 
relationships. Free Radic. Biol. Med. 1997, 22, 749–760. 
27. Kim, B.T.; O., K.J.; Chun, J.-C.; Hwang, K.-J. Synthesis of Dihydroxylated Chalcone Derivatives with 
Diverse Substitution Patterns and Their Radical Scavenging Ability toward DPPH Free Radicals. Bull. 
Korean Chem. Soc. 2008, 29, 6, doi:10.5012/bkcs.2008.29.6.1125. 
28. Fukuhara, K.; Nakanishi, I.; Kansui, H.; Sugiyama, E.; Kimura, M.; Shimada, T.; Urano, S.; Yamaguchi, K.; 
Miyata, N. Enhanced Radical-Scavenging Activity of a Planar Catechin Analogue. J. Am. Chem. Soc. 2002, 
124, 5952–5953, doi:10.1021/ja0178259. 
29. Deng, D.; Zhang, J.; Cooney, J.M.; Skinner, M.A.; Adaim, A.; Jensen, D.J.; Stevenson, D.E. Methylated 
polyphenols are poor “chemical” antioxidants but can still effectively protect cells from hydrogen 
peroxide-induced cytotoxicity. FEBS Lett. 2006, 580, 5247–5250, doi:10.1016/j.febslet.2006.08.051. 
30. Luo, W.; Wang, T.; Hong, C.; Yang, Y.C.; Chen, Y.; Cen, J.; Xie, S.Q.; Wang, C.J. Design, synthesis and 
evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents. 
Eur. J. Med. Chem. 2016, 122, 17–26, doi:10.1016/j.ejmech.2016.06.022. 
31. Jeong, J.M.; Choi, C.H.; Kang, S.K.; Lee, I.H.; Lee, J.Y.; Jung, H. Antioxidant and chemosensitizing effects 
of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J. Pharm. Pharm. 
Sci. 2007, 10, 537–546. 
32. Johansson, T.; Weidolf, L.; Jurva, U. Mimicry of phase I drug metabolism--novel methods for metabolite 
characterization and synthesis. Rapid Commun. Mass Spectrom. 2007, 21, 2323–2331, doi:10.1002/rcm.3077. 
33. Lohmann, W.; Karst, U. Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and 
limitations. Anal. Bioanal. Chem. 2008, 391, 79–96, doi:10.1007/s00216-007-1794-x. 
34. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying 
an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. 
35. Sugahara, S.; Ueda, Y.; Fukuhara, K.; Kamamuta, Y.; Matsuda, Y.; Murata, T.; Kuroda, Y.; Kabata, K.; Ono, 
M.; Igoshi, K.; et al. Antioxidant Effects of Herbal Tea Leaves from Yacon (Smallanthus sonchifolius) on 
Multiple Free Radical and Reducing Power Assays, Especially on Different Superoxide Anion Radical 
Generation Systems. J. Food Sci. 2015, 80, C2420–2429, doi:10.1111/1750-3841.13092. 
36. Clarke, G.; Ting, K.N.; Wiart, C.; Fry, J. High Correlation of 2,2-diphenyl-1-picrylhydrazyl (DPPH) Radical 
Scavenging, Ferric Reducing Activity Potential and Total Phenolics Content Indicates Redundancy in Use 
of All Three Assays to Screen for Antioxidant Activity of Extracts of Plants from the Malaysian Rainforest. 
Antioxidants (Basel) 2013, 2, 1–10, doi:10.3390/antiox2010001. 
Molecules 2018, 23, 3161 15 of 15 
 
37. Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: 
The FRAP assay. Anal. Biochem. 1996, 239, 70–76, doi:10.1006/abio.1996.0292. 
Sample Availability: Samples of the compounds are available from the authors. 
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
